Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2019-03-29

New gene therapy to treat rare inherited blood condition

View source ↗

Summary

The EMA announces a new gene therapy intended to treat a rare inherited blood condition, signaling a novel treatment option for affected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications